Cleared Special

K001356 - ONTRAK TESTCUP PRO-5

K001356 is the FDA 510(k) clearance for ONTRAK TESTCUP PRO-5 by Roche Diagnostics Corp.. It is a Class 2 Toxicology device (product code DJC) cleared through the Special 510(k) pathway after a 73-day FDA review.

K001356 · Roche Diagnostics Corp. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2000
Decision
73d
Days
Class 2
Risk

K001356 is an FDA 510(k) clearance for the ONTRAK TESTCUP PRO-5, MODEL 1986678. Classified as Thin Layer Chromatography, Methamphetamine (product code DJC), Class II - Special Controls.

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on July 10, 2000 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3610 - the FDA toxicology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Roche Diagnostics Corp. devices

Submission Details

510(k) Number K001356 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 28, 2000
Decision Date July 10, 2000
Days to Decision 73 days
Submission Type Special
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 87d · This submission: 73d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DJC Thin Layer Chromatography, Methamphetamine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3610
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DJC Thin Layer Chromatography, Methamphetamine

All 10
Devices cleared under the same product code (DJC) and FDA review panel - the closest regulatory comparables to K001356.
BIO-VENTURE Rapid Amphetamine Test Cassette for OTC Use, BIO-VENTURE Rapid Oxazepam Test Cassette for OTC Use, BIO-VENTURE Rapid Cocaine Test Cassette for OTC Use, BIO-VENTURE Rapid Methamphetamine Test Cassette for OTC Use, BIO-VENTURE Rapid Morphine Test Cassette for OTC Use, BIO-VENTURE Rapid Marijuana Test Cassette for OTC Use, BIO-VENTURE Rapid Amphetamine Test Cassette for Rx Use, BIO-VENTURE Rapid Oxazepam Test Cassette for Rx Use, BIO-VENTURE Rapid Cocaine Test Cassette for Rx
K180878 · Shanghai Venture Bio-Tech Co., Ltd. · Dec 2018
OralTox Oral fluid Drug Test
K181305 · Premier Biotech, Inc. · Sep 2018
OralTox Oral Fluid Drug Test
K171403 · Premier Biotech, Inc. · Feb 2018
DIALYSIS SYS., PDS 400 & RO 400
K781156 · Physio-Control Corp. · Oct 1978
KIDNEY, ARTIFICIAL
K781153 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Oct 1978
KIDNEY, ARTIFICIAL, C-DAK 2.0
K781237 · Cordis Corp. · Aug 1978